Cite
Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.
MLA
Priestley, Tony, et al. “Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.” Pain Medicine, vol. 19, no. 10, Oct. 2018, pp. 1988–96. EBSCOhost, https://doi.org/10.1093/pm/pnx235.
APA
Priestley, T., Chappa, A. K., Mould, D. R., Upton, R. N., Shusterman, N., Passik, S., Tormo, V. J., & Camper, S. (2018). Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers. Pain Medicine, 19(10), 1988–1996. https://doi.org/10.1093/pm/pnx235
Chicago
Priestley, Tony, Arvind K Chappa, Diane R Mould, Richard N Upton, Neil Shusterman, Steven Passik, Vicente J Tormo, and Stephen Camper. 2018. “Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.” Pain Medicine 19 (10): 1988–96. doi:10.1093/pm/pnx235.